(Q37354870)

19 August 2017

A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study (English)

1 reference

19 August 2017

1 reference

2

Kenji Wakai

1 reference

19 August 2017

Masashi Goto

1

1 reference

19 August 2017

Takashi Kawamura

3

1 reference

19 August 2017

Masahiko Ando

4

1 reference

19 August 2017

Masayuki Endoh

5

1 reference

19 August 2017

Yasuhiko Tomino

6

1 reference

19 August 2017

language of work or name

English

0 references

publication date

10 June 2009

1 reference

Nephrology Dialysis Transplantation

19 August 2017

1 reference

19 August 2017

24

1 reference

19 August 2017

10

1 reference

19 August 2017

3068-3074

1 reference

Revised equations for estimated GFR from serum creatinine in Japan

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

A family-based association study of megsin A23167G polymorphism with susceptibility and progression of IgA nephropathy in a Chinese population

6 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

6 September 2017

https://api.crossref.org/works/10.1093%2FNDT%2FGFP273

Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Epidemiologic data of primary glomerular diseases in western France

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Immunosuppressive agents for treating IgA nephropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Clinical guidelines of IgA nephropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

ACE gene polymorphism and IgA nephropathy: an ethnically homogeneous study and a meta-analysis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

[Intercapillary deposits of IgA-IgG]

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Angiotensin-converting-enzyme inhibitors slow renal decline in IgA nephropathy, independent of tubulointerstitial fibrosis at presentation

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Néphrologues de l'Est.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2747499

IgA Nephropathy: The Presence of Familial Disease Does Not Confer an Increased Risk for Progression

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFP273

Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men

21 January 2018

1 reference

12 December 2020

Increased risk of end-stage renal disease in familial IgA nephropathy

1 reference

12 December 2020

Toward individual prognosis of IgA nephropathy

1 reference

12 December 2020

Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses

1 reference

12 December 2020

Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy

1 reference

12 December 2020

ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study

1 reference

12 December 2020

Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy

1 reference

12 December 2020

Significance of urinalysis for subsequent kidney and urinary tract disorders in mass screening of adults

1 reference

12 December 2020

Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy

1 reference

12 December 2020

1 reference

12 December 2020

Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study

1 reference

12 December 2020

Identifiers

DOI

10.1093/NDT/GFP273

1 reference

19 August 2017

1 reference

19 August 2017

1 reference